Disability in Valued Life Activities Among Individuals with COPD and Other Respiratory Conditions
Overview
Authors
Affiliations
Purpose: The purpose of this study was to delineate the effect of chronic obstructive pulmonary disease (COPD) on a broad range of valued life activities (VLAs) and make comparisons to effects of other airways conditions.
Methods: We used cross-sectional data from a population-based, longitudinal study of US adults with airways disease. Data were collected by telephone interview. VLA disability was compared among 3 groups defined by reported physician diagnoses: COPD/emphysema, chronic bronchitis, and asthma. Multiple regression analyses were conducted to identify independent predictors of VLA disability.
Results: About half of individuals with COPD were unable to perform at least 1 VLA; almost all reported at least 1 VLA affected. The impact among individuals with chronic bronchitis and asthma was less but still notable: 74%-84% reported at least 1 activity affected, and about 15% were unable to perform at least 1 activity. In general, obligatory activities were the least affected. Symptom measures and functional limitations were the strongest predictors of disability, independent of respiratory condition.
Conclusion: VLA disability is common among individuals with COPD. Obligatory activities are less affected than committed and discretionary activities. A focus on obligatory activities, as is common in disability studies, would miss a great deal of the impact of these conditions. Because individuals are often referred to pulmonary rehabilitation as a result of dissatisfaction with ability to perform daily activities, VLA disability may be an especially relevant outcome for rehabilitation.
Disability and long-term breathlessness: a cross-sectional, population study.
Kochovska S, Ferreira D, Chang S, Brunelli V, Morgan D, Similowski T BMJ Open Respir Res. 2024; 11(1).
PMID: 39038915 PMC: 11268077. DOI: 10.1136/bmjresp-2023-002029.
Anderson E, Wiener R, Molloy-Paolillo B, McCullough M, Kim B, Harris J PLoS One. 2023; 18(6):e0286326.
PMID: 37352241 PMC: 10289382. DOI: 10.1371/journal.pone.0286326.
Roberts M, Mapel D, Ganvir N, Dodd M Int J Chron Obstruct Pulmon Dis. 2022; 17:701-717.
PMID: 35411140 PMC: 8994612. DOI: 10.2147/COPD.S348714.
Fuentes-Alonso M, Lopez-Herranz M, Lopez-de-Andres A, Ji Z, Jimenez-Garcia R, Maestre-Miquel C J Clin Med. 2021; 10(13).
PMID: 34202915 PMC: 8268632. DOI: 10.3390/jcm10132786.
Katz P, Pedro S, Trupin L, Yelin E, Michaud K ACR Open Rheumatol. 2021; 3(4):221-230.
PMID: 33609085 PMC: 8063140. DOI: 10.1002/acr2.11212.